Gujarat Kidney And Super Speciality Limited
NSE: GKSLINE0V0W01025·Healthcare·www.gujaratsuperspecialityhospital.com ↗·Mcap ₹1,401 Cr·Listed 2025
₹178.02▲ ₹7.17  (4.20%)
52W: ₹98 – ₹187 · Vol: 18.3L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q2 FY26
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26
Revenue from operations34.330.623.212.9
Other income0.70.70.10.1
Total expenses2826.618.39
EBITDA8.46.36.95.1
EBITDA margin24.4%20.6%29.7%39.6%
Finance costs0.70.80.60.3
Depreciation1.41.51.30.9
Profit before tax74.754
Tax1.6−0.11.31.2
Net profit5.34.83.72.9
Net margin15.5%15.8%15.9%22.2%
EPS (₹)0.660.810.520.52

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26
Revenue from operations82
Other income0.9
Total expenses61.7
EBITDA26.9
EBITDA margin32.8%
Finance costs1.9
Depreciation4.7
Profit before tax21.2
Tax4.4
Net profit16.8
Net margin20.5%
EPS (₹)2.49
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26
Operating cash flow−3.9
Investing cash flow−214
Financing cash flow228
Capital expenditure10.8
Free cash flow (CFO − capex)−14.7

Net profit trend

annual, ₹ crore
FY26
₹16.8

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated14 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone14 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited–PDF on NSE XBRL
Q4 FY26Consolidated · audited29 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited29 May 2026PDF on NSE XBRL
Q3 FY26Consolidated–PDF on NSE XBRL
Q3 FY26Consolidated15 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone–PDF on NSE XBRL
Q3 FY26Standalone15 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated–PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 47.5×83.9×
P/B5Y avg 3.16×5.56×
ROEFY26, on average equity6.7%
Net margin20.5%
Debt / equity0.06×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹2.12
Market cap₹1,404 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
5.56×
vs 1-point avg 3.16× (+76%)
3.16× low3.16× avg5.56× high
History points are balance-sheet dates (2026 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹298 Cr
Net worth₹253 Cr
Total borrowings₹16 Cr
Cash & bank balances₹13 Cr
Investments₹0 Cr
Inventories₹2 Cr
Trade receivables₹39 Cr
Trade payables₹8 Cr
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Dec 25
Promoter71.4571.4571.4571.45
FII4.884.8810.4713.09
DII0.560.561.677.84
Retail10.6410.6411.567.51
Other public12.4712.474.850.11
18,301 shareholders · NSE shareholding pattern filings.